nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Urine abnormality—Formoterol—chronic obstructive pulmonary disease	0.029	0.029	CcSEcCtD
Gadobutrol—Urine abnormality—Arformoterol—chronic obstructive pulmonary disease	0.029	0.029	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Formoterol—chronic obstructive pulmonary disease	0.0273	0.0273	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0273	0.0273	CcSEcCtD
Gadobutrol—Injection site pain—Formoterol—chronic obstructive pulmonary disease	0.0197	0.0197	CcSEcCtD
Gadobutrol—Injection site pain—Arformoterol—chronic obstructive pulmonary disease	0.0197	0.0197	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.0158	0.0158	CcSEcCtD
Gadobutrol—Abnormal vision—Formoterol—chronic obstructive pulmonary disease	0.014	0.014	CcSEcCtD
Gadobutrol—Abnormal vision—Arformoterol—chronic obstructive pulmonary disease	0.014	0.014	CcSEcCtD
Gadobutrol—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0135	0.0135	CcSEcCtD
Gadobutrol—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0124	0.0124	CcSEcCtD
Gadobutrol—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.0122	0.0122	CcSEcCtD
Gadobutrol—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0112	0.0112	CcSEcCtD
Gadobutrol—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Gadobutrol—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00962	0.00962	CcSEcCtD
Gadobutrol—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00926	0.00926	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00923	0.00923	CcSEcCtD
Gadobutrol—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00892	0.00892	CcSEcCtD
Gadobutrol—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00831	0.00831	CcSEcCtD
Gadobutrol—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00815	0.00815	CcSEcCtD
Gadobutrol—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00799	0.00799	CcSEcCtD
Gadobutrol—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00786	0.00786	CcSEcCtD
Gadobutrol—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00777	0.00777	CcSEcCtD
Gadobutrol—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00777	0.00777	CcSEcCtD
Gadobutrol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00772	0.00772	CcSEcCtD
Gadobutrol—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00768	0.00768	CcSEcCtD
Gadobutrol—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00757	0.00757	CcSEcCtD
Gadobutrol—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00752	0.00752	CcSEcCtD
Gadobutrol—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00747	0.00747	CcSEcCtD
Gadobutrol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00746	0.00746	CcSEcCtD
Gadobutrol—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00724	0.00724	CcSEcCtD
Gadobutrol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00717	0.00717	CcSEcCtD
Gadobutrol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00711	0.00711	CcSEcCtD
Gadobutrol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00711	0.00711	CcSEcCtD
Gadobutrol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00707	0.00707	CcSEcCtD
Gadobutrol—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00705	0.00705	CcSEcCtD
Gadobutrol—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00687	0.00687	CcSEcCtD
Gadobutrol—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00687	0.00687	CcSEcCtD
Gadobutrol—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00681	0.00681	CcSEcCtD
Gadobutrol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0067	0.0067	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00652	0.00652	CcSEcCtD
Gadobutrol—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00649	0.00649	CcSEcCtD
Gadobutrol—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00642	0.00642	CcSEcCtD
Gadobutrol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00637	0.00637	CcSEcCtD
Gadobutrol—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.0062	0.0062	CcSEcCtD
Gadobutrol—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.0062	0.0062	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00615	0.00615	CcSEcCtD
Gadobutrol—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00607	0.00607	CcSEcCtD
Gadobutrol—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00595	0.00595	CcSEcCtD
Gadobutrol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00595	0.00595	CcSEcCtD
Gadobutrol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00595	0.00595	CcSEcCtD
Gadobutrol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00595	0.00595	CcSEcCtD
Gadobutrol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00585	0.00585	CcSEcCtD
Gadobutrol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00584	0.00584	CcSEcCtD
Gadobutrol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00584	0.00584	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0058	0.0058	CcSEcCtD
Gadobutrol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00573	0.00573	CcSEcCtD
Gadobutrol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00573	0.00573	CcSEcCtD
Gadobutrol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00569	0.00569	CcSEcCtD
Gadobutrol—Infection—Formoterol—chronic obstructive pulmonary disease	0.00569	0.00569	CcSEcCtD
Gadobutrol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00561	0.00561	CcSEcCtD
Gadobutrol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00561	0.00561	CcSEcCtD
Gadobutrol—Infection—Montelukast—chronic obstructive pulmonary disease	0.00557	0.00557	CcSEcCtD
Gadobutrol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00554	0.00554	CcSEcCtD
Gadobutrol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00552	0.00552	CcSEcCtD
Gadobutrol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00541	0.00541	CcSEcCtD
Gadobutrol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00537	0.00537	CcSEcCtD
Gadobutrol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00531	0.00531	CcSEcCtD
Gadobutrol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00523	0.00523	CcSEcCtD
Gadobutrol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00523	0.00523	CcSEcCtD
Gadobutrol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00518	0.00518	CcSEcCtD
Gadobutrol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00518	0.00518	CcSEcCtD
Gadobutrol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00515	0.00515	CcSEcCtD
Gadobutrol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00511	0.00511	CcSEcCtD
Gadobutrol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00511	0.00511	CcSEcCtD
Gadobutrol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00507	0.00507	CcSEcCtD
Gadobutrol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00504	0.00504	CcSEcCtD
Gadobutrol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00498	0.00498	CcSEcCtD
Gadobutrol—Pain—Formoterol—chronic obstructive pulmonary disease	0.0049	0.0049	CcSEcCtD
Gadobutrol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0049	0.0049	CcSEcCtD
Gadobutrol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00489	0.00489	CcSEcCtD
Gadobutrol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Gadobutrol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00482	0.00482	CcSEcCtD
Gadobutrol—Pain—Montelukast—chronic obstructive pulmonary disease	0.0048	0.0048	CcSEcCtD
Gadobutrol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00478	0.00478	CcSEcCtD
Gadobutrol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00474	0.00474	CcSEcCtD
Gadobutrol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00474	0.00474	CcSEcCtD
Gadobutrol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00471	0.00471	CcSEcCtD
Gadobutrol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00468	0.00468	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00468	0.00468	CcSEcCtD
Gadobutrol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00462	0.00462	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00459	0.00459	CcSEcCtD
Gadobutrol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Gadobutrol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Gadobutrol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Gadobutrol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Gadobutrol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00451	0.00451	CcSEcCtD
Gadobutrol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00447	0.00447	CcSEcCtD
Gadobutrol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00447	0.00447	CcSEcCtD
Gadobutrol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00447	0.00447	CcSEcCtD
Gadobutrol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Gadobutrol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00443	0.00443	CcSEcCtD
Gadobutrol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00443	0.00443	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00442	0.00442	CcSEcCtD
Gadobutrol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.00427	CcSEcCtD
Gadobutrol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.00427	CcSEcCtD
Gadobutrol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00422	0.00422	CcSEcCtD
Gadobutrol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00422	0.00422	CcSEcCtD
Gadobutrol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00421	0.00421	CcSEcCtD
Gadobutrol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00421	0.00421	CcSEcCtD
Gadobutrol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00413	0.00413	CcSEcCtD
Gadobutrol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00398	0.00398	CcSEcCtD
Gadobutrol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Gadobutrol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00392	0.00392	CcSEcCtD
Gadobutrol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Gadobutrol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Gadobutrol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Gadobutrol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00379	0.00379	CcSEcCtD
Gadobutrol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Gadobutrol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Gadobutrol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Gadobutrol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Gadobutrol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Gadobutrol—Rash—Formoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Gadobutrol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Gadobutrol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Gadobutrol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Gadobutrol—Headache—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Gadobutrol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Gadobutrol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Gadobutrol—Rash—Montelukast—chronic obstructive pulmonary disease	0.00354	0.00354	CcSEcCtD
Gadobutrol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Gadobutrol—Headache—Montelukast—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Gadobutrol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00344	0.00344	CcSEcCtD
Gadobutrol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Gadobutrol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Gadobutrol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00341	0.00341	CcSEcCtD
Gadobutrol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0034	0.0034	CcSEcCtD
Gadobutrol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0034	0.0034	CcSEcCtD
Gadobutrol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Gadobutrol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00333	0.00333	CcSEcCtD
Gadobutrol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Gadobutrol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Gadobutrol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.0031	0.0031	CcSEcCtD
Gadobutrol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Gadobutrol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.0028	CcSEcCtD
Gadobutrol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00278	0.00278	CcSEcCtD
Gadobutrol—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00265	0.00265	CcSEcCtD
Gadobutrol—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00248	0.00248	CcSEcCtD
Gadobutrol—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00239	0.00239	CcSEcCtD
Gadobutrol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Gadobutrol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00225	0.00225	CcSEcCtD
Gadobutrol—Infection—Prednisone—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Gadobutrol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Gadobutrol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Gadobutrol—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00204	0.00204	CcSEcCtD
Gadobutrol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00202	0.00202	CcSEcCtD
Gadobutrol—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00196	0.00196	CcSEcCtD
Gadobutrol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Gadobutrol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00194	0.00194	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Gadobutrol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00184	0.00184	CcSEcCtD
Gadobutrol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Gadobutrol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Gadobutrol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00166	0.00166	CcSEcCtD
Gadobutrol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Gadobutrol—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Gadobutrol—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Gadobutrol—Rash—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Gadobutrol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00142	CcSEcCtD
Gadobutrol—Headache—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Gadobutrol—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
